By literature search, we excluded the previously reported prognostic biomarkers of gliomas, and obtained two gene signatures (HSPA5 and MTPN) that can predict the prognosis of both white and Asian populations (Norris et al., 2016; Li et al., 2014; Ge et al., 2018; Yan et al., 2019). This evidence concerns the gene MTPN and glioma.